Ticker CRVOListed on Nasdaq
CervoMed Inc.
At a glance
Most recent filing on October 23, 2026 — a grant by Blackburn Kelly on Oct 22, 2026.
We hold 3 Form 4 lines, going back to October 23, 2026.
Insider trades
How to read a Form 4All 3 shown
- Blackburn Kelly EVP, Clinical Development19,100 sharesGrant
- De Rosch Mark EVP, RA and GA and PgM19,100 sharesGrant
- Winton Matthew Chief Commercial and Business19,100 sharesGrant
CEO pay
What the company reported for its principal executive officer, usually the CEO, in the pay-versus-performance table of its proxy statement. The total counts shares and options at their value on the day they were granted. Actually paid counts them at the change in their value during the year, so it can be far higher or lower than the total, and negative. A dash means the company reported no amount.
Dr. Alam, fiscal year ended Dec 31, 2025: total $1,047,620, actually paid $1,521,702. First reported Apr 30, 2026.
Earlier fiscal years are part of the subscription.